Table 4. Patient data during and after ECMO support of system-exchange patients.
| Acute | Elective | p-value | |
| Patients (n) | 37 | 46 | |
| Stay in ICU (days) | 32 (19–43) | 38 (24–47) | 0.106 |
| Intubation (days) | 23 (16–43) | 32 (23–45) | 0.045 |
| ARF on ECMO (n; %) | 10; 27 | 13; 33 | 0.903 |
| Amount of MOs | 2.0 (2.0–2.0) | 2.0 (2.0–3.0) | 0.079 |
| Cumulative support time (days) | 744 | 733 | |
| Support time 1st MO (days) | 7.0 (5.0–10.3) | 9.5 (7.0–13.0) | 0.023 |
| ECMO duration (days) | 17.0 (11.8–26.0) | 22.0 (15.0–30.0) | 0.095 |
| Successful weaning (n; %) | 28; 76 | 29; 63 | - |
| Died on ECMO (n; %) | 9; 17 | 17; 29 | 0.320 |
| RBC/days ECMO | 0.24 (0.00–0.72) | 0.32 (0.25–0.56) | 0.147 |
| FFP/days ECMO | 0.00 (0.00–0.01) | 0.00 (0.00–0.33) | 0.054 |
| PC/days ECMO | 0.00 (0.00–0.01) | 0.00 (0.00–0.06) | 0.488 |
Data are presented as median (interquartile range) except for successful weaning and acute renal failure on ECMO. MO, membrane oxygenator; ICU, intensive care unit; RBC, red blood cells; FFP, fresh frozen plasma (1 FFP contains 230 ml plasma); PC, platelet concentrate (1 PC contains 250 ml and 2–4×1011 thrombocytes); ARF, acute renal failure.